HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel method of screening cell-cycle blockers as candidates for anti-tumor reagents using yeast as a screening tool.

Abstract
The mechanisms of eukaryotic cell-cycle regulation are closely linked to cellular tumorigenesis. Compounds that affect the cell cycle are good candidates for developing anti-tumor drugs. We developed a screening method for cell-cycle blockers using a Saccharomyces cerevisiae cdc2-1 rad9Delta strain that can detect the activity of substances by cell growth. We performed screening on culture broth of various microbes, and identified five compounds, borrelidin, mycophenolic acid, UCS15A, copiamycin analog, and fredericamycin A, that were known to possess anti-tumor activity. These results indicate that this screening method is effective as a first-screening system for anti-tumor agents.
AuthorsEiko Tsuchiya, Masashi Yukawa, Masaru Ueno, Ken-Ichi Kimura, Hidetoshi Takahashi
JournalBioscience, biotechnology, and biochemistry (Biosci Biotechnol Biochem) Vol. 74 Issue 2 Pg. 411-4 ( 2010) ISSN: 1347-6947 [Electronic] England
PMID20139596 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Cell Cycle Proteins
Topics
  • Antineoplastic Agents (pharmacology)
  • Cell Cycle (drug effects)
  • Cell Cycle Proteins (metabolism)
  • Cell Proliferation (drug effects)
  • Drug Screening Assays, Antitumor
  • Humans
  • Neoplasms (metabolism)
  • Saccharomyces cerevisiae (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: